Related content

The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer

By Wang Linrun   Wu Xiuhua   Huang Mingzhu   Cai Jie   Xu Nong   Liu Jian  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 211-218

Springer Publishing Company

Access to resources Recommend Favorite

Gemictabine plus carboplatin in patients with advanced non-small cell lung cancer

By Park Se   Jeong Seong   Kyung Sun   Lim Young-Hee   An Chang   Lee Sang   Park Jeong   Bang Soo   Cho Eun   Shin Dong   Lee Jae  

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 359-366

Humana Press, Inc

Access to resources Recommend Favorite

Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer

By Baron F.   Cueva J.   Grana B.   Curiel T.   Leon L.   Vazquez F.   Candamio S.   Lopez R.  

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1381-1384

Elsevier

Access to resources Recommend Favorite

Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer

By Wang Lin   Huang Ming   Zhang Guo   Xu Nong   Wu Xiu  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 601-607

Springer Publishing Company

Access to resources Recommend Favorite

Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer

By Soetekouw Patricia   Timmer-Bonte Johanna   Drift Miep   Leeuwen Frank   Wagenaar Michiel   Die Lya   Bussink Jan   Tjan-Heijnen Vivianne  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 988-996

Springer Publishing Company

Access to resources Recommend Favorite